New lab-made compounds tested on cancer cells in a dish
Original title: Dihydropyrimidinone-isatin hybrids as potent inducers of cell-cycle arrest and caspase-dependent apoptosis in MV4-11 acute myeloid leukemia cells.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done on cells in a dish in a lab.
The short version
Scientists made new chemical compounds and tested them on cancer cells in the lab, including brain tumor cells.
What was studied. Researchers built a new set of lab-made compounds called DHPM-isatin hybrids. They tested them on three kinds of cancer cells grown in a dish: acute myeloid leukemia cells, glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells, and neuroblastoma cells.
What they found. One compound, called 7k, worked the best. It slowed the growth of the leukemia cells better than cisplatin, a chemotherapy drug. It was also gentler on normal skin cells than cisplatin was. In the leukemia cells, it stopped the cells from dividing and pushed them to die off.
What this means, and what it doesn't
What it could mean: This is very early science. It suggests one new compound is worth studying further. It does not change any treatment choice you or your doctor would make now.
What it doesn't mean: This does not mean there is a new treatment. The work was done on cells in a dish, not in people or even in animals. Most compounds at this stage never become a medicine. The brain tumor cells were only part of the first screening, and the report focused on the leukemia cells. This is not a cure, and it is many years and many studies away from anything a patient could receive.
Source: PubMed, August 5, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.